Eledon Pharmaceuticals Capital Expenditures (CapEx) Growth & History (ELDN)

Eledon Pharmaceuticals's capital expenditures (capex) was $9,000 for fiscal 2016.

View full Eledon Pharmaceuticals company overview

Eledon Pharmaceuticals annual capital expenditures (capex) history

Eledon Pharmaceuticals annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20162016-12-31$9,000−$556,000−98.41%
20152015-12-31$565,000$540,000+2160.00%
20142014-12-31$25,000$2,000+8.70%
20132013-12-31$23,000$15,000+187.50%
20122012-12-31$8,000

Eledon Pharmaceuticals capital expenditures (capex) trends

Between the periods ended 2012-12-31 and 2016-12-31, Eledon Pharmaceuticals's capital expenditures (capex) increased from $8,000 to $9,000, a change of $1,000. The latest reported quarter, Q4 2016, shows $3,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Eledon Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about ELDN yet. Start the conversation.

Write the first post